The regulatory framework for microbiome-based therapies: insights into European regulatory developments.

Area of Science:

• Microbiome research
• Regulatory science
• European Union policy

Background:

• The development of microbiome-based therapies is rapidly advancing.
• Existing regulatory frameworks require adaptation to accommodate these novel treatments.
• European regulatory landscapes are evolving in response to therapeutic innovations.

Purpose of the Study:

• To review innovative microbiome-based therapies.
• To provide an overview of the current European regulatory framework.
• To analyze the impact of the Regulation on substances of human origin (SoHO) on microbiome therapy development.

Main Methods:

• Literature review of microbiome therapies.
• Analysis of European regulatory documents, specifically the SoHO regulation.
• Synthesis of regulatory changes and their implications.

Main Results:

• A broad spectrum of microbiome therapies is emerging.
• The Regulation on substances of human origin (SoHO) introduces significant changes.
• Current regulations present challenges for microbiome therapy development.

Conclusions:

• Microbiome regulatory science is crucial for realizing the potential of these therapies.
• Adaptation of regulatory frameworks is necessary to support innovation.
• The SoHO regulation necessitates a focused approach to microbiome therapeutics.